Skip to main content
. 2021 Oct 13;50(D1):D771–D776. doi: 10.1093/nar/gkab895

Figure 2.

Figure 2.

Distribution of mutation sites associated with >5 mAbs in the Receptor binding domain of SARS-CoV-2 spike protein. Variant sites with potential impact on neutralization of human polyclonal sera are represented in red. Cumulative frequencies of variants at RBD sites are mentioned alongside.